Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Viking Therapeutics
Biotech
Viking sails oral weight loss drug to ph 2 after clinical win
Novo Nordisk may be racing to get an oral successor to its Wegovy weight loss sensation through clinical trials, but Viking is sailing up close behind.
James Waldron
Mar 26, 2024 10:04am
As Madrigal lands MASH nod, what's next for biotechs in pursuit?
Mar 15, 2024 10:55am
Viking's GLP-1 spurs steep weight loss, sending shares up 80%
Feb 27, 2024 10:15am
Akero's NASH miss drags a few peers down, spurring deja vu
Oct 11, 2023 10:50am
Prospective NASH market flips from failure to overcrowded
Aug 10, 2023 6:00am
Terns’ phase 2 NASH trial hits but differentiation doubts go on
Aug 9, 2023 4:43am